News

White brings more than 24 years of successful experience in the in vitro diagnostic marketplace to BG Medicine, including roles at innovative leading companies such as QIAGEN, Digene,

Luna Innovations announced its financial results for the fourth quarter and year ended December 31, 2008. As against the same quarter last year, fourth quarter 2008 revenues down

Avigen, a biopharmaceutical company, has announced that two preclinical reports with glial attenuator AV411 support the pharmacological effect of the drug on enhancing the pain-killing effect of opioids

Basilea Pharmaceutica has filed claims in arbitration against Johnson & Johnson and affiliated companies related to delays in approval of ceftobiprole. Basilea submitted a request for arbitration to

Nihon Kohden’s Patient Monitoring solutions utilize miniaturization technology and processing to provide clinicians with a feature rich value oriented product offering. Mike Dashefsky, vice president, patient monitoring, says,

In his role, Lusk will lead the national sales force, manage international distribution, and drive activities to market the Celerus Wave System, the first and only solution to

Celution System and StemSource product sales accounted for $4.5 million of the total. The company anticipates 2009 product revenues of at least $10 million. Product revenue in 2009

Net income in 2008 was $68.4 million, or $0.47 per diluted share, compared to a net loss of $21.1 million, or $0.08 per diluted share, in 2007. Total

As vice president of business-to-business and Puerto Rico, Mr Azar will oversee the company’s public payer, managed care and wholesaler operations in the US as well as oversee